6 reasons you shouldn’t bet on blockchain disrupting healthcare

[Image from Daniel von Appen on Unsplash]

Blockchain is the big buzzword these days, bruited as a disruptive force for industries covering the spectrum. But there seems to be little understanding of what exactly “blockchain” means, let alone how it could affect so many different markets so profoundly.

Simply put, a blockchain is a decentralized database with tight rules about how data is entered, maintained and accessed. Instead of being stored at a single location, the data in a blockchain are stored in a series of discrete nodes. Think of it as a connected series of ledgers, each with identical data. Because each transaction must be exactly the same across all the ledgers, blockchains are “very difficult to work with, expensive to maintain, hard to upgrade and a pain to scale,” writes developer Jimmy Song at the Medium website.

“The main thing distinguishing a blockchain from a normal database is that there are specific rules about how to put data into the database. That is, it cannot conflict with some other data that’s already in the database (consistent), it’s append-only (immutable), and the data itself is locked to an owner (ownable), it’s replicable and available. Finally, everyone agrees on what the state of the things in the database are (canonical) without a central party (decentralized),” according to Song. “It is this last point that really is the holy grail of blockchain. Decentralization is very attractive because it implies there is no single point of failure. That is, no single authority will be able to take away your asset or change ‘history’ to suit their needs. This immutable audit trail where you don’t have to trust anyone is the benefit that everyone that’s playing with this technology is looking for. This benefit, however, comes at a great cost.”

Here are the six factors Song cites as reasons why blockchain is great for one specific task but terrible for most of the others its hyped for, including healthcare:

  1. Development is stricter and slower. Because the blockchain’s data must be consistent across all of its nodes, a tiny error in one place can corrupt the entire database. Perhaps worse, that bug could render some data different in one node than in the other nodes. “There is no ‘move fast and break things’ in a blockchain,” Song explains. “If you break things, you lose consistency and the blockchain becomes corrupted and worthless.” And its incredibly hard to fix a bug, he adds, because all users must agree to any changes. “The blockchain has to be a public resource that’s not under the control of a single entity,” he says.
  2. Incentive structures are difficult to design. Ensuring that bad-actor users can’t abuse or corrupt the blockchain means creating incentives that span the gap between a low barrier to data entry – resulting in frivolous, useless data – and a too-high barrier resulting in a blockchain with almost no data. “What gives the data finality? How can you ensure that the rewards are aligned with the network goals? Why do nodes keep or update the data and what makes them choose one piece of data over another when they are in conflict? These are all incentive questions that need good answers and they need to be aligned not just at the beginning but at all points in the future as technology and companies change, otherwise the blockchain is not useful,” Song writes.
  3. Maintenance is very costly. That’s because, compared with a centralized model in which tasks are performed only once, with blockchain those functions must run thousands of times.
  4. Users are sovereign. Bad actors can’t be booted from your blockchain for entering frivolous data or gaming the system for profit, because there’s no governing entity with the authority to do it. “The blockchain has to be impartial and enforce the rules defined by the software. If the rules are insufficient to deter bad behavior, you’re out of luck,” according to Song.
  5. A forced upgrade is not an option. “The point of a blockchain is that it’s not under the control of a single entity and this is violated with a forced upgrade,” he explains. That means all upgrades must be backwards-compatible, making the addition of new features and testing new versions extremely challenging.
  6. Scaling is really hard. “The same data has to live in hundreds or thousands of places [rather] than in a single place. The overhead of transmission, verification and storage is enormous as every single copy of the database must pay them instead of those costs being paid just once in a traditional, centralized database.

Most of the industries looking to blockchain for salvation really need upgrades to their IT infrastructure, especially the “notoriously terrible” software used by the healthcare industry, Song says.

“What’s clear is that a lot of companies looking to use the blockchain are not really wanting a blockchain at all, but rather IT upgrades to their particular industry,” he says.

The post 6 reasons you shouldn’t bet on blockchain disrupting healthcare appeared first on MassDevice.

NIH launches precision medicine project to collect health data from one million volunteers

Credit: NIH

The National Institutes of Health will open national enrollment next week for its All of Us research program, aiming to collect health data from at least one million volunteers across the country.

The project, which has been in beta for the last year, will request health and lifestyle data from volunteers using online surveys and electronic health records.

Get the full story at our sister site, Drug Delivery Business News.

The post NIH launches precision medicine project to collect health data from one million volunteers appeared first on MassDevice.

MediMergent and FDA team up to tackle medication adherence

Healthcare data analytics company, MediMergent, and the FDA’s Center for Drug Evaluation and Research reportedly gathered stakeholders from biopharma companies, pharmacies, health plans and regulatory agencies to propose strategies regarding medication non-adherence.

Approximately half of all Americans with chronic diseases who need lifelong medications do not stick to their prescribed regimen six months after they begin therapy, according to MediMergent. It’s a problem that results in up to $300 billion in added healthcare costs, the company said.

Get the full story at our sister site, Drug Delivery Business News.

The post MediMergent and FDA team up to tackle medication adherence appeared first on MassDevice.

Study: Digital tools prove useful for kids with Type I diabetes

A six-month study found that children and teenagers with Type I diabetes who participated in an intensive remote therapy pilot program saw improved blood glucose control compared to those who received traditional care.

The study, conducted by UnitedHealth (NYSE:UNH) and Children’s Hospitals & Clinics of Minnesota, was published last month in the journal Pediatric Diabetes.

Get the full story at our sister site, Drug Delivery Business News.

The post Study: Digital tools prove useful for kids with Type I diabetes appeared first on MassDevice.

Optum CEO Renfro steps down to lead expanded investment fund

In a major personnel shift, UnitedHealth Group (NYSE:UNH) announced this week that Larry Renfro, CEO of its subsidiary Optum, will step away from the corner office to become managing partner of Optum Ventures and its expanded $600 million investment fund.

Ex-GlaxoSmithKline (NYSE:GSK) chief executive, Andrew Witty, will take Renfro’s place as CEO of Optum on July 1, the company announced March 13. Witty has been a member of UnitedHealth’s board since August of 2017.

Get the full story at our sister site, Medical Design & Outsourcing.

The post Optum CEO Renfro steps down to lead expanded investment fund appeared first on MassDevice.

How the Apple Watch & other wearables could help highlight early signs of diabetes

  • Steve Maxson joins Fermatex as VP of marketing and sales

    Fermatex Vascular Technologies (formerly Gore-Jersey Shore and Adam Spence Corporation) recently announced that Steve Maxson has joined the company as VP of marketing and sales. “I’m very pleased to have Steve join the Fermatex team at this exciting time of transition and growth. His technical experience and commitment to responsive service will ensure that we remain […]

  • Nearly 90% of clinicians will use bedside mobile tech by 2022, study says

    A new study from Zebra Technologies reports that 9 out of 10 clinicians will use mobile technology at the bedside for acute care within the next four years. The company received feedback from 1,500 nursing managers, IT decision-makers and patients to determine how patient care will transform by 2022. The ability to use mobile devices […]

  • Trumpf touts newest laser technology at Photonics West

    Trumpf is touting its TruMicro 5370 and TruMicro 7380, Dira 200-5 and a TruLaser Station 5005 with a TruMicro 2030 laser system Photonics West in San Francisco, Calif. at booth #817. The company’s short and ultra-short pulsed TruMicro 5370 and 7380 lasers are designed for micro-processing. They are used in standard processing methods like cutting, drilling, […]

  • Dow touts versatility in latest LSR grades for overmolding

    Dow Medical Solutions, a business unit of the DowDuPont Specialty Products Division has introduced two new liquid silicone rubber (LSR) technologies to support a broader range of rigid plastic substrates for overmolding applications. These new elastomeric products give designers and manufacturers greater options for creating differentiated devices with improved safety and durability. The two grades include […]

  • Spectralytics launches DFM product development facility for laser services

    In the new medtech manufacturing environment, design engineers need parts faster, with fewer iterations and quicker turnaround. Spectralytics aims to meet those needs with its revamped development center in Maple Plain, Minn. The laser cutting and processing contract manufacturer has a newly expanded facility dedicated to design and prototyping. The 15,000 sq. ft. facility is located […]

  • Mack Molding systematizes ISO 9001 and 13485 revisions

    Mack Molding recently announced that is has started the process of systematizing ISO 9001:2015 and ISO 13485:2016 fifth and third revisions for medical devices. The company plans to train internal auditors to help assure that Mack Molding is ready to be certified after audits that are scheduled for July. “When we first implemented ISO 9001 […]

  • GW Plastics expands in-house tooling capabilities

    GW Plastics (Royalton, Vt.) recently announced that it has expanded and upgraded its tooling facility, adding additive manufacturing technology. The company has invested in medical 3D printing technology to help with conformal cooling and improve cycle times up to 30%. “This additive manufacturing technology streamlines tool design, reducing the components needed to build a mold […]

  • Raumedic investing in modernizing headquarters

    Raumedic (Helmbrechts, Germany) is investing 1 million Euros in expanding and modernizing its German headquarters. The company will add a state-of-the-art customer center while improving working conditions for employees. The company is adding a new foyer with additional meeting areas. The older buildings at the Helmbrechts-based headquarters will be the main areas undergoing modernization, which […]

  • Software is a top cause of medical device recalls: Here’s what you can do

    Stericycle Expert Solutions recently conducted a five-year assessment of recall trends, based on its quarterly Recall Index studies. The results show surprising missteps from medical device companies, especially where software is concerned. We asked Chris Harvey, director of recall solutions at Stericycle to answer some questions about the recall trends and offer some advice on […]

  • Report: Medical device recalls down in Q4 of 2017

    The medical device industry saw a 9% decline in recalls in the last quarter of 2017, the lowest quarter since the fourth quarter of 2011. Stericycle Expert Solutions reports in its annual Recall Index that one of the major causes of medical device recalls over the past five years is technological advances. Chris Harvey, director […]

  • Webinar: How a 3D printer’s versatility enables medical innovation

    Wednesday, Feb. 21, 2018 11:30am Eastern time / 8:30am Pacific time     View this webinar to learn how 3D printing’s versatility has paved the way for medical advancements by Cardiovascuar Systems. To help fight the battle against CAD and PAD, CSI works continuously to advance their devices and develop new innovations – work that […]

  • How blockchains could empower patients and secure data

    Share
    chrissa mcfarlane

    Chrissa McFarlane, founder and CEO of Patientory [Image from LinkedIn]

    Blockchains are best known as the technology behind cryptocurrencies such as Bitcoin. But the founders of a young Atlanta-based company called Patientory think they could have another important use – securing health data and empowering patients along the way.

    Secure access to patient data is a major issue for the healthcare industry. Patients have a hard time accessing their records and hospital networks need to transfer the data between networks if a patient chooses a new provider. That process can take days to complete, and even then, the patient doesn’t own their data.

    “The biggest burden we have is getting access to patient data,” said Chrissa McFarlane, Patientory’s CEO and founder.

    Get the full story on our sister site, Medical Design & Outsourcing.

    One Drop wants to help lead a healthcare revolution for people with diabetes – here’s how

    Share

    One DropWhen Jeff Dachis was diagnosed with Type I diabetes four years ago, he remembers leaving the doctor’s office with a sinking feeling in his chest.

    “I had about six minutes with a nurse practitioner and was given an insulin pen and a prescription and a pat on the back – and I was out the door,” he told Drug Delivery Business News. “I was concerned for my family, I was concerned for my kids. I didn’t really know what this was going to mean for me.”

    He found himself searching for devices or products to help him manage his diabetes. From counting carbohydrates to calculating insulin doses, diabetes is a data-driven disease.

    Get the full story at our sister site, Drug Delivery Business News.